Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesiology, Perioperative, and Pain Medicine, Brigham and Women’s Hospital, and Harvard Medical School, Boston, MA 02115, USA.
Sci Rep. 2012;2:639. doi: 10.1038/srep00639. Epub 2012 Sep 6.
Mechanisms underlying delays in resolution programs of inflammation are of interest for many diseases. Here, we addressed delayed resolution of inflammation and identified specific microRNA (miR)-metabolipidomic signatures. Delayed resolution initiated by high-dose challenges decreased miR-219-5p expression along with increased leukotriene B(4) (5-fold) and decreased (~3-fold) specialized pro-resolving mediators, e.g. protectin D1. Resolvin (Rv)E1 and RvD1 (1 nM) reduced miR-219-5p in human macrophages, not shared by RvD2 or PD1. Since mature miR-219-5p is produced from pre-miRs miR-219-1 and miR-219-2, we co-expressed in human macrophages a 5-lipoxygenase (LOX) 3'UTR-luciferase reporter vector together with either miR-219-1 or miR-219-2. Only miR-219-2 reduced luciferase activity. Apoptotic neutrophils administered into inflamed exudates in vivo increased miR-219-2-3p expression and PD1/NPD1 levels as well as decreased leukotriene B(4). These results demonstrate that delayed resolution undermines endogenous resolution programs, altering miR-219-2 expression, increasing pro-inflammatory mediators and compromising SPM production that contribute to failed catabasis and homeostasis.
炎症消退方案延迟的机制是许多疾病研究的热点。在这里,我们研究了炎症消退的延迟,并确定了特定的 microRNA(miR)-代谢脂质组学特征。高剂量刺激引发的延迟消退会降低 miR-219-5p 的表达,同时增加白三烯 B4(增加 5 倍),并降低(减少约 3 倍)特殊的促消退介质,例如保护素 D1。解析素(Rv)E1 和 RvD1(1 nM)降低人巨噬细胞中的 miR-219-5p,但 RvD2 或 PD1 则没有这种作用。由于成熟的 miR-219-5p 是由前体 miR-219-1 和 miR-219-2 产生的,我们在人巨噬细胞中共表达了一个 5-脂氧合酶(LOX)3'UTR-荧光素酶报告载体,与 miR-219-1 或 miR-219-2 一起。只有 miR-219-2 降低了荧光素酶活性。体内注入到炎症渗出物中的凋亡中性粒细胞增加了 miR-219-2-3p 的表达和 PD1/NPD1 水平,同时降低了白三烯 B4。这些结果表明,延迟消退会破坏内源性消退程序,改变 miR-219-2 的表达,增加促炎介质的产生,并损害 SPM 的产生,从而导致代谢衰退和内稳态失败。